Literature DB >> 14739690

The association of sexual dysfunction and substance use among a community epidemiological sample.

Sharon D Johnson1, Deborah L Phelps, Linda B Cottler.   

Abstract

This study examines the prevalence of DSM-III sexual dysfunctions and their association with comorbid drug and alcohol use in a community epidemiologic sample. The data for these analyses are based on the Epidemiological Catchment Area Project, a multistage probability study of the incidence and prevalence of psychiatric disorders in the general population conducted in 1981-83. Only the sample of 3,004 adult community residents in the St. Louis area was queried on DSM-III sexual dysfunctions of inhibited orgasm, functional dyspareunia (painful sex), inhibited sexual excitement (i.e., lack of erection/arousal), and inhibited sexual desire. There was a prevalence rate of 11% for inhibited orgasm, 13% for painful sex, 5% for inhibited sexual excitement, 7% for inhibited sexual desire, and 26% for any of these sexual dysfunctions (14% for men and 33% for women). The prevalence of qualifying lifetime substance use among the population was 37%, with males meeting more drug and alcohol use criteria than females. After controlling for demographics, health status variables, and psychiatric comorbidity (depression disorder, generalized anxiety disorder, antisocial personality disorder, and residual disorders), inhibited orgasm was associated with marijuana and alcohol use. Painful sex was associated with illicit drug use and marijuana use. Inhibited sexual excitement was more likely among illicit drug users. Inhibited sexual desire was not associated with drug or alcohol use.

Entities:  

Mesh:

Year:  2004        PMID: 14739690     DOI: 10.1023/B:ASEB.0000007462.97961.5a

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  24 in total

1.  A Qualitative Investigation Comparing Psychosocial and Physical Sexual Experiences Related to Alcohol and Marijuana Use among Adults.

Authors:  Joseph J Palamar; Patricia Acosta; Danielle C Ompad; Samuel R Friedman
Journal:  Arch Sex Behav       Date:  2016-07-20

Review 2.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

3.  [Sexual dysfunction and its consequences in patients with cardiovascular diseases].

Authors:  C Günzler; L Kriston; A Agyemang; D Riemann; M M Berner
Journal:  Herz       Date:  2010-07-28       Impact factor: 1.443

4.  Circulating endocannabinoid concentrations and sexual arousal in women.

Authors:  Carolin Klein; Matthew N Hill; Sabrina C H Chang; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Sex Med       Date:  2012-03-29       Impact factor: 3.802

Review 5.  Cannabinoid signalling and effects of cannabis on the male reproductive system.

Authors:  Mauro Maccarrone; Cinzia Rapino; Felice Francavilla; Arcangelo Barbonetti
Journal:  Nat Rev Urol       Date:  2020-11-19       Impact factor: 14.432

6.  Sexual Functioning in Adolescents With Major Depressive Disorder.

Authors:  Emira Deumic; Brandon D Butcher; Anita D Clayton; Lilian N Dindo; Trudy L Burns; Chadi A Calarge
Journal:  J Clin Psychiatry       Date:  2016-07       Impact factor: 4.384

7.  Influences of situational factors and alcohol expectancies on sexual desire and arousal among heavy-episodic drinking women: acute alcohol intoxication and condom availability.

Authors:  Amanda K Gilmore; William H George; Hong V Nguyen; Julia R Heiman; Kelly Cue Davis; Jeanette Norris
Journal:  Arch Sex Behav       Date:  2013-05-10

8.  A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men.

Authors:  Raouf Seyam
Journal:  Ther Adv Urol       Date:  2013-10

Review 9.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

10.  Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations.

Authors:  Geoffrey M Reed; Jack Drescher; Richard B Krueger; Elham Atalla; Susan D Cochran; Michael B First; Peggy T Cohen-Kettenis; Iván Arango-de Montis; Sharon J Parish; Sara Cottler; Peer Briken; Shekhar Saxena
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.